MktsMarkets

Benitec Biopharma Inc.
NASDAQ: BNTCKey statistics
BNTC News
Stories mentioning BNTC from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | |||||||
| Operating Expenses | ||||||||
| Research & Development | 6,298 | 5,834 | 3,370 | 2,867 | 6,495 | 5,385 | 3,585 | 3,512 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 13,582 | 13,377 | 9,803 | 9,834 | 15,335 | 10,805 | 5,791 | 5,548 |
| Operating Income (Loss) | (13,582) | (13,377) | (9,803) | (9,834) | (15,335) | (10,805) | (5,791) | (5,548) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (17.00) | 19.00 | (84.00) | (126.00) | 0.00 | (40.00) | 35.00 | (154.00) |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (11,935) | (11,837) | (8,965) | (8,805) | (14,501) | (9,552) | (5,059) | (4,720) |
| Earnings Per Share (Basic) | (0.24) | (0.26) | (0.22) | (0.21) | (0.38) | (0.26) | (0.18) | (0.26) |
| Earnings Per Share (Diluted) | (0.24) | (0.26) | (0.22) | (0.21) | (0.38) | (0.26) | (0.18) | (0.26) |
| Weighted Average Shares Outstanding (Basic) | 49,386 | 45,971 | 41,521 | 41,161 | 38,599 | 37,255 | 27,884 | 18,364 |
| Weighted Average Shares Outstanding (Diluted) | 49,386 | 45,971 | 41,521 | 41,161 | 38,599 | 37,255 | 27,884 | 18,364 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BNTC
Benitec Biopharma Inc. (NASDAQ: BNTC) is a stock listed on the Nasdaq Stock Market under the ticker symbol BNTC. It last traded at $8.27 (Nov 18, 2026, 4:00 PM ET), up 1.5% on the day. That gives Benitec Biopharma a market capitalisation of $290.2M.
Over the past 52 weeks BNTC has traded between $7.88 and $14.39.
Revenue for the quarter ended Mar 31, 2026 was $0; a net loss of $11.9M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | $0 | -$11.9M |
| Dec 31, 2025 | $0 | -$11.8M |
| Sep 30, 2025 | $0 | -$9.0M |
| Jun 30, 2025 | — | -$8.8M |
From Benitec Biopharma’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…